Loading clinical trials...
Loading clinical trials...
Cytokine-induced killer (CIK) cells will be co-cultured with HPV induced dendritic cells (DCs); HPV specific DC-CIK will be induced to Condylomata Acuminata patients using interferon, whose recurrence...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shenzhen Second People's Hospital
NCT02520986 · Condylomata Acuminata
NCT03935204 · Condylomata Acuminata, Cervical Cancer
NCT03546842 · Papillomavirus Infections, Uterine Cervical Neoplasms, and more
NCT01796821 · Condyloma Acuminata, Genital Warts, and more
NCT03853785 · Condylomata Acuminata
Shenzhen Second Hospital
Shenzhen, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions